Home / MOTS : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does MOTS make money? Does MOTS have pricing power? What's the Earnings Whisper? Will MOTS profit more as the business scales? What is MOTS's management track record? Is MOTS's current price justified?

Motus GI Holdings, Inc.

$0 +$0.00 (+100.00%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

Day Range

$0$0

Year Range

$0$0.1

Market Cap

1.28K

AVG Volume

1.82K

Trailing/Forward PE

-0/-

PEG ratio

Dividend Yield

Next Earnings Date

2026-11-17

Primary Exchange

Other OTC

Revenue (USD)

MOTS Revenue (USD) by year
Period	Revenue (USD)
2023	319K
2022	592K
2021	391K
2020	98K
2019	107K
2018	36K
2017	-10K
2016	0

Net Income (USD)

MOTS Net Income (USD) by year
Period	Net Income (USD)
2023	-12.87M
2022	-19.93M
2021	-19.03M
2020	-19.26M
2019	-23.09M
2018	-22.26M
2017	-13.2M
2016	-7.99M

Operating Income (USD)

MOTS Operating Income (USD) by year
Period	Operating Income (USD)
2023	-11.91M
2022	-17.85M
2021	-17.92M
2020	-19.05M
2019	-23.44M
2018	-18.92M
2017	-12.96M
2016	-5.97M

EBITDA (USD)

MOTS EBITDA (USD) by year
Period	EBITDA (USD)
2023	-11.48M
2022	-16.51M
2021	-17.59M
2020	-18.17M
2019	-23.21M
2018	-18.77M
2017	-12.96M
2016	-6.23M

Cash Flows (USD)

MOTS Cash Flows (USD) by year
Period	Cash Flows (USD)
2023	-11.5M
2022	-17.69M
2021	-14.89M
2020	-17.08M
2019	-20.38M
2018	-15.48M
2017	-11.11M
2016	-6.16M

EPS (USD)

MOTS EPS (USD) by year
Period	EPS (USD)
2023	-25.85
2022	-99.76
2021	-122.75
2020	-187.39
2019	-283.32
2018	-452.31
2017	-382.99
2016	-183.56

Expenses (USD)

MOTS Expenses (USD) by year
Period	Expenses (USD)
2023	11.76M
2022	17.87M
2021	18.16M
2020	18.74M
2019	23.88M
2018	19.45M
2017	13.66M
2016	5.97M

Cash & Debt (USD)

MOTS Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2023	4.96M
2022	14.04M
2021	22.56M
2020	20.82M
2019	28.73M
2018	21.09M
2017	7.01M
2016	11.64M

Debt ratios

MOTS Debt ratios by year
Period	Debt ratios
2023	0.04
2022	0.03
2021	0.13
2020	0.16
2019	0.33

Margins

MOTS Margins by year
Period	Margins
2023	-103.45%
2022	-34.46%
2021	-59.59%
2020	-406.12%
2019	-27.1%
2018	-61.11%
2017	-60%

Return on Capital

MOTS Return on Capital by year
Period	Return on Capital
2023	-478.86%
2022	-669.3%
2021	-197.09%
2020	-170.58%
2019	-125.96%
2018	-120.19%
2017	-239.02%
2016	-79.63%

Shares Outstanding

MOTS Shares Outstanding by year
Period	Shares Outstanding
2023	1.55M
2022	309.79K
2021	161.02K
2020	125.98K
2019	96.01K
2018	54.01K
2017	34.88K
2016	42.37K

Book Value Per Share (USD)

MOTS Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2023	1.73
2022	9.61
2021	59.97
2020	89.61
2019	190.9
2018	342.87
2017	158.34
2016	236.68

Total Assets (USD)

MOTS Total Assets (USD) by year
Period	Total Assets (USD)
2023	7.22M
2022	17.65M
2021	26.09M
2020	24.06M
2019	32.26M
2018	22.95M
2017	9.17M
2016	12.19M

Employee Count

MOTS Employee Count by year
Period	Employee Count
2023	15
2022	43
2021	30
2020	24
2019	49
2018	44
2017	39

Free Cash Flow Yield

MOTS Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-503877.55%
Sep 26	-503877.54%
Aug 26	-1007755.1%
Aug 26	-1007755.1%
Aug 26	-1007755.1%
Aug 26	-1007755.1%
Jul 26	-1007755.07%
Jul 26	-1007755.1%
Jul 26	-1007755.1%
Jul 26	-1007755.1%
Jul 26	-1007755.07%
Jun 26	-1007755.1%
Jun 26	-1007755.1%
Jun 26	-1007755.07%
Jun 26	-1007755.1%
May 26	-1007755.1%
May 26	-1007755.1%
May 26	-1007755.1%
May 26	-1007755.1%
May 26	-1007755.1%
Apr 26	-1007755.1%
Apr 26	-1007755.1%
Apr 26	-1007755.1%
Apr 26	-1007755.1%
Mar 26	-1007755.1%
Mar 26	-1007755.1%
Mar 26	-1007755.1%
Mar 26	-1007755.1%
Feb 26	-1007755.07%
Feb 26	-503877.55%
Feb 26	-503877.55%
Feb 26	-1007755.1%
Jan 26	-1007755.1%
Jan 26	-100775507%
Jan 26	-1007755.1%
Jan 26	-1007755.1%
Jan 26	-1007755.1%
Dec 25	-1007755.07%
Dec 25	-1007755.1%
Dec 25	-1007755.1%
Dec 25	-1007755.1%
Nov 25	-1007755.07%
Nov 25	-503877.54%
Nov 25	-503877.54%
Nov 25	-1007755.1%
Oct 25	-1007755.1%
Oct 25	-503877.54%
Oct 25	-1007755.1%
Oct 25	-1007755.1%
Oct 25	-10077550.7%
Sep 25	-10077550.7%
Sep 25	-1007755.07%
Sep 25	-1007755.1%
Sep 25	-1007755.1%
Aug 25	-100775507%
Aug 25	-1007755.07%
Aug 25	-1007755.1%
Aug 25	-1007755.07%
Aug 25	-100775507%
Jul 25	-1007755.1%
Jul 25	-1007755.07%
Jul 25	-335918.34%
Jul 25	-335918.34%
Jun 25	-335918.34%
Jun 25	-335918.34%
Jun 25	-335918.34%
Jun 25	-335918.34%
May 25	-335918.34%
May 25	-335918.34%
May 25	-1007755.1%
May 25	-1007755.1%
May 25	-1007755.1%
Apr 25	-1007755.1%
Apr 25	-1007755.1%
Apr 25	-1007755.1%
Apr 25	-1007755.1%
Mar 25	-1007755.1%
Mar 25	-1007755.1%
Mar 25	-1007755.1%
Mar 25	-1007755.1%
Feb 25	-1007755.1%
Feb 25	-1007755.1%
Feb 25	-503877.55%
Feb 25	-503877.55%
Jan 25	-1007755.07%
Jan 25	-1007755.07%
Jan 25	-1007755.07%
Jan 25	-1007755.1%
Jan 25	-1007755.07%
Dec 24	-1007755.07%
Dec 24	-1007755.07%
Dec 24	-503877.54%
Dec 24	-251938.77%
Nov 24	-1007755.07%
Nov 24	-335918.36%
Nov 24	-251938.77%
Nov 24	-251938.77%
Nov 24	-100775.51%
Oct 24	-67183.67%
Oct 24	-80620.41%

Price to Sales

MOTS Price to Sales by year
Period	Price to Sales
Sep 26	0.01
Sep 26	0.01
Aug 26	0
Aug 26	0
Aug 26	0
Aug 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jun 26	0
Jun 26	0
Jun 26	0
Jun 26	0
May 26	0
May 26	0
May 26	0
May 26	0
May 26	0
Apr 26	0
Apr 26	0
Apr 26	0
Apr 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Feb 26	0
Feb 26	0.01
Feb 26	0.01
Feb 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Dec 25	0
Dec 25	0
Dec 25	0
Dec 25	0
Nov 25	0
Nov 25	0.01
Nov 25	0.01
Nov 25	0
Oct 25	0
Oct 25	0.01
Oct 25	0
Oct 25	0
Oct 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Jul 25	0
Jul 25	0
Jul 25	0.01
Jul 25	0.01
Jun 25	0.01
Jun 25	0.01
Jun 25	0.01
Jun 25	0.01
May 25	0.01
May 25	0.01
May 25	0
May 25	0
May 25	0
Apr 25	0
Apr 25	0
Apr 25	0
Apr 25	0
Mar 25	0
Mar 25	0
Mar 25	0
Mar 25	0
Feb 25	0
Feb 25	0
Feb 25	0.01
Feb 25	0.01
Jan 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Dec 24	0
Dec 24	0
Dec 24	0.01
Dec 24	0.01
Nov 24	0
Nov 24	0.01
Nov 24	0.01
Nov 24	0.01
Nov 24	0.03
Oct 24	0.04
Oct 24	0.03

Price to Book

MOTS Price to Book by year
Period	Price to Book
Sep 26	0
Sep 26	0
Aug 26	0
Aug 26	0
Aug 26	0
Aug 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jun 26	0
Jun 26	0
Jun 26	0
Jun 26	0
May 26	0
May 26	0
May 26	0
May 26	0
May 26	0
Apr 26	0
Apr 26	0
Apr 26	0
Apr 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Feb 26	0
Feb 26	0
Feb 26	0
Feb 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Dec 25	0
Dec 25	0
Dec 25	0
Dec 25	0
Nov 25	0
Nov 25	0
Nov 25	0
Nov 25	0
Oct 25	0
Oct 25	0
Oct 25	0
Oct 25	0
Oct 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Jul 25	0
Jul 25	0
Jul 25	0
Jul 25	0
Jun 25	0
Jun 25	0
Jun 25	0
Jun 25	0
May 25	0
May 25	0
May 25	0
May 25	0
May 25	0
Apr 25	0
Apr 25	0
Apr 25	0
Apr 25	0
Mar 25	0
Mar 25	0
Mar 25	0
Mar 25	0
Feb 25	0
Feb 25	0
Feb 25	0
Feb 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Dec 24	0
Dec 24	0
Dec 24	0
Dec 24	0
Nov 24	0
Nov 24	0
Nov 24	0
Nov 24	0
Nov 24	0
Oct 24	0
Oct 24	0

No video analysis for this stock yet. Request one from our team.

News: MOTS

accessnewswire.com · 28 Jul 2026

Vanta Commends U.S. FDA Advisory Committee Vote Recommending Inclusion of Six Peptide Substances on FDA's 503A Bulks List, Including BPC-157, TB-500 and MOTS-c

News Release Highlights: U.S. FDA Pharmacy Compounding Advisory Committee recommends the inclusion of six peptide substances, including BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax, on the FDA's 503A Bulks List, representing a significant step in the FDA's ongoing regulatory review process for these peptide substances. Vanta has established a strategic operating framework supporting its contemplated U.S. peptide platform, including telehealth-enabled commercialization, FDA-registered compounding pharmacy coordination, peptide manufacturing and fulfillment capabilities, and compliant payment processing infrastructure.

AI Analysis

Motus GI Holdings, Inc.

Video analysis: MOTS

News: MOTS

Vanta Commends U.S. FDA Advisory Committee Vote Recommending Inclusion of Six Peptide Substances on FDA's 503A Bulks List, Including BPC-157, TB-500 and MOTS-c

Similar companies